跳到主要內容

Booth Bruce 的 Form 4 申報

Kymera Therapeutics, Inc.(KYMR),2026/6/30 申報

申報編號
0001451612-26-000020
申報時間
2026/6/30
交易日
2026/6/29
申報延遲
1 天
10b5-1 計畫
有勾選

這份申報列了 8 筆非衍生性交易。公開市場賣出合計 $342.5 萬。交易後 1 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Booth BruceCIK 0001451612董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2026/6/29Common StockS賣出處分−10,658$108.28F2−$1,154,048.242,402,089間接
2026/6/29Common StockS賣出處分−7,833$109.75F4−$859,671.752,394,256間接
2026/6/29Common StockS賣出處分−7,602$110.67F5−$841,313.342,386,654間接
2026/6/29Common StockS賣出處分−907$111.20F6−$100,858.42,385,747間接
2026/6/29Common StockS賣出處分−1,688$108.28F2−$182,776.64464,389間接
2026/6/29Common StockS賣出處分−1,239$109.75F4−$135,980.25463,150間接
2026/6/29Common StockS賣出處分−1,199$110.67F5−$132,693.33461,951間接
2026/6/29Common StockS賣出處分−157$111.20F6−$17,458.4461,794間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.0326 to $109.019 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold each separate price within the ranges set forth in footnotes (2) and (4) through (6).

表 I 有 2 筆交易的價格引用這則附註。

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.034 to $109.96 inclusive.

表 I 有 2 筆交易的價格引用這則附註。

F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.09 to $111.08 inclusive.

表 I 有 2 筆交易的價格引用這則附註。

F6

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.09 to $111.63 inclusive.

表 I 有 2 筆交易的價格引用這則附註。

備註

Due to the 30 line limitation in Table I, this report is being filed across two forms. This is the second of two filings.

看 SEC EDGAR 上的完整原文 (在新分頁開啟)